Sangamo BioSciences | SGMO - Kapitalisasi Pasar





Kapitalisasi Pasar Perubahan Tanggal
Alaunos Therapeutics USD 7M 2M 2026-03
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Alterity Therapeutics Limited AUD 39M 17M 2026-09
Amgen USD 195.44B 5.55B 2026-06
Bayer EUR 47.56B 8.87B 2026-06
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Cipla INR 1.18T 194.93B 2026-06
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.29M 475.62M 2026-03
CSL USD 55.89B 20.42B 2025-12
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Merck USD 317.37B 20.27B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Tectonic Therapeutic USD 580M 190M 2026-03
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06